Clinicopathologic Features of Large B-cell Lymphomas with Concurrent Cytogenetic Abnormalities in MYC and BCL2: Improved Clinical Behavior with Modern Interventions

被引:0
|
作者
Lee, Yi-Shan [1 ]
Frater, John L. [1 ]
Kreisel, Friederike H. [1 ]
Ruzinova, Marianna B. [1 ]
Hassan, Anjum [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1413
引用
收藏
页码:357A / 358A
页数:2
相关论文
共 50 条
  • [31] MYC and BCL2 Gene Rearrangements in Comparison to MYC and BCL2 Protein Expression in AIDS-Related Diffuse Large B Cell Lymphomas
    Nam, Anna
    Mathew, Susan
    Liu, Yen-Chun
    Chadburn, Amy
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [32] Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas
    Testo, Natalia
    Olson, Luke C.
    Subramaniyam, Shivakumar
    Hanson, Ty
    Magro, Cynthia M.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2016, 38 (10) : 769 - 774
  • [33] C-MYC and bCL2 translocation frequency in diffuse large B cell lymphomas
    Akkaya, H.
    Akkaya, B.
    Salim, O.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    VIRCHOWS ARCHIV, 2015, 467 : S195 - S195
  • [34] C-MYC AND BCL2 TRANSLOCATION FREQUENCY IN DIFFUSE LARGE B CELL LYMPHOMAS
    Akkaya, B.
    Salim, O.
    Akkaya, H.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    HAEMATOLOGICA, 2015, 100 : 395 - 395
  • [35] Concurrent Overexpression of MYC and BCL2 by Dual Immunohistochemistry Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
    Roh, Jin
    Yoon, Dok Hyun
    Huh, Jooryung
    Park, Chan-Sik
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [36] Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements Clinicopathologic Features of 11 Cases
    Wang, Wei
    Hu, Shimin
    Lu, Xinyan
    Young, Ken H.
    Medeiros, L. Jeffrey
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1132 - 1139
  • [37] Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements
    Yoshida, Maki
    Ichikawa, Ayako
    Miyoshi, Hiroaki
    Kiyasu, Junichi
    Kimura, Yoshizo
    Arakawa, Fumiko
    Niino, Daisuke
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2015, 65 (10) : 519 - 527
  • [38] Complex BCL2/IGH/MYC rearrangements in diffuse large B-cell lymphoma
    Sales, Mark
    Cunningham, J. J. P.
    Kernohan, N. M.
    Smith, G. D.
    Maliszewska, C. T.
    Pratt, N. R.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S132 - S132
  • [39] Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)
    Habermann, Thomas M.
    Macon, William R.
    Maurer, Matthew J.
    Ketterling, Rhett P.
    Kurtin, Paul J.
    Feldman, Andrew L.
    Vaidya, Rakhee
    Cerhan, James R.
    Ansell, Stephen
    Porrata, Luis
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    McPhail, Ellen D.
    BLOOD, 2016, 128 (22)
  • [40] Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence
    Bogusz, Agata M.
    Kovach, Alexandra E.
    Le, Long P.
    Feng, Derek
    Baxter, Richard H. G.
    Sohani, Aliyah R.
    PLOS ONE, 2017, 12 (02):